Patent · US Active

Method for dual inhibition of SGLT1 and SGLT2 using diphenylmethane derivatives

US9340521B2 · kind B2 · utility

2Cited by
0References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 18, 2013
Grant dateMay 17, 2016
Priority date
Expiry dateDec 9, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D409/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention relates to a method for dual inhibition of sodium-dependent glucose cotransporter 1 (SGLT1) and sodium-dependent glucose cotransporter 2 (SGLT2) present in the intestine and kidney by using the compound of formula I or a pharmaceutically acceptable salt or a prodrug thereof:wherein ring A, ring B, X and Y have the same meanings as defined in the specification.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.